Keyphrases
Pulmonary Fibrosis
100%
Acute Respiratory Distress Syndrome
100%
Mesenchymal Stromal Cells
100%
New Therapeutic Approaches
100%
Survivors
33%
New Therapeutic Strategies
16%
Therapeutical Approaches
16%
Lung Disorders
16%
COVID-19 Outbreak
16%
Lung Transplantation
16%
Definitive Treatment
16%
Gas Exchange
16%
SARS-CoV-2 Infection
16%
Multiple Organ Dysfunction Syndrome
16%
Major Adverse Events
16%
Adult Patients
16%
Allogeneic Bone
16%
COVID-19 Pandemic
16%
Mesenchymal Stem Cell Therapy
16%
Moderate COVID-19
16%
COVID-19 Related
16%
Therapeutical Strategies
16%
PaO2
16%
Human Mesenchymal Stem Cells (hMSCs)
16%
Patient-completed
16%
Long-term Sequelae
16%
FiO2
16%
ICU Discharge
16%
Allogeneic Mesenchymal Stromal Cells
16%
Post-inflammatory
16%
Medicine and Dentistry
Pulmonary Fibrosis
100%
Mesenchymal Stem Cell
100%
Acute Respiratory Distress Syndrome
100%
COVID-19
50%
Sequela
16%
Adverse Event
16%
Lactate Dehydrogenase
16%
Lifespan
16%
Clinical Study
16%
Cell Therapy
16%
Lung Transplantation
16%
Multiple Organ Dysfunction Syndrome
16%
Infusion
16%
Severe Acute Respiratory Syndrome
16%
Infection
16%
Silo-Filler's Disease
16%
Gas Exchange
16%
INIS
fibrosis
100%
applications
100%
patients
50%
covid-19
50%
lungs
33%
doses
33%
investigations
33%
safety
16%
gases
16%
therapy
16%
inflammation
16%
death
16%
adults
16%
infusion
16%
bone marrow
16%
